New research has discovered a unique and promising avenue for diagnosing Alzheimer’s disease (AD) earlier—by analyzing AD biomarkers in blood—so that the impacts of dementia can be reduced.
Novel biomarker could lead to early diagnosis of Alzheimer’s disease, pilot study suggests
